Work

What is the risk of pneumonia associated with adalimumab in a patient with COPD, rheumatoid arthritis, moderate emphysema, and asthma?

Year: 2026

Type: article

Abstract: No direct evidence for the specific risk of pneumonia associated with adalimumab in a patient with COPD, RA, moderate emphysema, and asthma was identified. However, there is an elevated general risk of serious infections, including pneumonia, with adalimumab treatment, particularly when used alongside other immunosuppressants.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.23666107

Author: Tripdatabase

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7223667089

FWCI:

Cites:

Cited by:

Related to: 10